Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Gastroenteropancreatic neuroendocrine neoplasms are fairly rare tumors with very heterogeneous behavior and molecular characteristics. Their generally slow proliferation render them virtually resistant to many DNA damaging therapeutic approaches. Bortezomib has been shown to be effective in GEP-NENs in vitro but has been withdrawn from clinical assessment due to a small phase II study on bortezomib monotherapy in 2004.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Briest F
Authors: Briest F, Christen F, Worpenberg L, Welzel M, Freitag H,
Keywords: GEP-NEN, targeted therapy, DNA repair, chemotherapy,
Introduction: Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) are heterogeneous in their clinical behavior and therapeutic options are still not satisfactory. The “crosstalk” of different signaling pathways in NEN cells appears to be more complex as known already. PKI-587 is a highly potent novel dual inhibitor of PI3K and mTORC1/C2.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Freitag H, Briest F, Christen F, Grass I, Lewens F,
Keywords: dual inhibition, PI3K, mTOR, PKI-587,RAD001, signaling,
#1084 Pancreatic Neuroendocrine Tumors in Denmark and Introduction of Cancer Package Pathways
Introduction: New referral procedures were introduced into the Danish healthcare system on Jan 1, 2009 in malignant diseases. Cancer-package pathways purposed to streamline diagnostics and treatment specifically to reduce the waiting time from diagnosis to initiation of specialized treatment.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Christensen C
Authors: Christensen C, Grønbæk H,